Terapia UGD si BRGE Flashcards

1
Q

IPP - reprezentanti

A
Omeprazol
Esomeprazol
Lansoprazol
Pantoprazol
Rabeprazol
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Mecanism de actiune IPP

A

blocarea ireversibila a ATPazei H+/K+ dependente prin legarea covalenta de enzima

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Activare IPP

A

Promedicamente - dupa absorbtie, se concentreaza in in canaliculele secretorii ale cel parietale (mediu acid) unde sunt transformare in sulfenamide tetraciclice care se leaga de pompa de protoni

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Indicatii IPP

A

Ulcer gastro-duodenal
BRGE
Sindrom Zollinger-Ellison (de electie)
Eradicarea HP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Administrarea IPP

A

Oral - dimineata cu 30 min inainte de masa

Parenteral

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Farmacocinetica IPP

A

Absorbtie buna dupa admin orala
Metabolizare extensiva hepatica (CYP2C19, CYP3A4)
Eliminare renala sau prin scaun (lansoprazol)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Reactii adverse IPP

A

Mascheaza simptomatologia cancerului gastric
Hipomagneziemie
Hipergastrinemie
Hipersecretie acida de rebound la intreruperea brusca a tratamentului
Creste riscul de infectii pulmonare si digestive cu C diff
Creste incidenta fracturii de col femural la femei

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Interactiuni medicamentoase IPP

A

Datorita metabolizarii prin sist CYP450 - warfarina, diazepam, ciclosporina, fenitoina, teofilina
Scaderea aciditatii gastrice - diminua abs ketoconazol, Fe, ampicilina, digoxin
Scade ef antiagregant al clopidogrelului

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Antagonisti H2 reprezentanti

A

Cimetidina
Famotidina
Ranitidina
Nizatidina

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Antagonistii H2 - mecanism de actiune

A

Blocarea competitiva a R H2 pentru His -> impiedica efectele excito-secr gastrice ale His

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Indicatii anti-H2

A

UGD
BRGE, esofagita de reflux
Sindrom Zollinger Ellison
Tratamentul de intretinere si prevenirea recurentelor in UGD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Farmacocinetica anti-H2

A
Administrare orala, abs buna, Bd medie
Leg P plasmatice mica
Metab hep redusa
Eliminare renala -> ! reducerea dozelor in IR
Trece BFP si in lapte
! TOLERANTA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Reactii adverse - CIMETIDINA

A

Ginecomastie, galactoree, oligospermie si impotenta (blocheaza R androgenici)
Hipersecretie acida de rebound la intreruperea brusca a tratamentului
Creste riscul evenimentelor toxice prin inhibarea sistemului enzimatic al CYP450

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Mecanism de actiune antiacide

A

Neutralizeaza aciditatea (baze slabe), reduc activitatea pepsinei -> actiune simptomatica

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Clasificare antiacide

A
  1. SISTEMICE - se absorb, iar la doze mari produc acidoza metabolica
  2. NESISTEMICE - nu se absorb, nu modif ech AB
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Farmacocinetica antiacide

A

Administrare orala - Bd cea mai buna pentru formele lichide

Efect prelungit daca sunt administrate dupa masa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Indicatii antiacide

A

Boala ulceroasa
Manifestari sporadice BRGE
Pirozis - tratament simptomatic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Interactiuni medicamentoase antiacide

A

Scad absorbtia medicamentelor administrate simultan - pauza 2h
Scad absorbtia compusilor care necesita mediu acid

19
Q

Hidroxidul de aluminiu - actiune

A

Lenta si durabila - antipeptica (absoarbe si inactiveaza pepsina), leaga acizii biliari, creste eliminarea fecala de fosfati, intarzie golirea stomacului

20
Q

Hidroxid de Al - reactii adverse

A

Constipatie
Carenta de fosfati (tratament cronic)
Fenomene toxice in IR (osteodistrofie + miopatie proximala + encefalopatie)

21
Q

Compusii de magneziu - actiune

A
rapida, intensa, scurta
Nu se absorb -> saruri insolubile care se elimina prin scaun
Proprietati laxative (asoc cu comp de Al)
22
Q

Carbonatul de calciu - actiune

A

rapida, intensa, durabila
hipersecretie acida de rebound
efect antidiareic

23
Q

Carbonat de Ca - RA

A

Hipercalcemie cronica
Calculoza renala
Constipatie, balonare, flatulenta
Sindrom lapte-alcaline (alcaloza metabolica + hipercalcemie + IR)

24
Q

Bicarbonatul de Na

A

Antiacid sistemic -> prod alcaloza metabolica
Produce distensie gastrica si balonare
CI: IC, HTA, IR

25
Q

Simeticona

A

surfactant cu ef antispumant
scade RGE
reduce balonarea si flatulenta

26
Q

Misoprostol - mecanism de actiune

A

Analog de PGE2 -> scade secretia de HCl, ef citoprotector, amelioreaza circulatie, favorizeaza procesele de vindecare

27
Q

Farmacocinetica misoprostol

A

Absorbtie buna
Metabolizare hepatica
Eliminare renala

28
Q

Indicatii misoprostol

A

ulcere digestive dupa utilizarea AINS

UD

29
Q

Misoprostol - RA

A

Favorizeaza contractia musculaturii netede (efect ocitocic) - diaree (trecatoare), colici, poate declansa avortul sau nasterea prematura

30
Q

Misoprostol - CI

A

Sarcina

31
Q

Sucralfat - mecanism de actiune

A

Zaharoza sulfatata + Al(OH)3 - elibereaza Al, se incarca negativ, se leaga de mucine => gel complex cu rol protect (Adera mai ales de ulcer), leaga SB, ef antiinflamator, creste secr si vascozit mucusului, stimuleaza secr PG

32
Q

Sucralfat - indicatii

A
UD
gastropatie, UG cu reflux biliar
profilaxia ulcerelor de stres
mucosita orala si proctita post iradiere
ulcere rectale solitare
33
Q

Administrare sucralfat

A

Inainte de masa (30 min - 1h) si seara la culcare (4/zi)

34
Q

RA sucralfat

A

Constipatie

xerostomie, fen toxice, cefalee, greturi, varsaturi, rash, laringospasm

35
Q

CI sucralfat

A

IR - datorita cont de Al

36
Q

Subcitratul de bismut coloidal - actiune

A

Pp in prez HCl -> depozit cristalin pe resturile P de la supraf lez ulceroase (!activ doar in prez nisei ulceroase) cu rol protector
Actiune toxica pe HP

37
Q

Bi subcitrat - RA & CI

A

RA: greturi, innegrirea scaunului
CI: IR, sarcina, asoc cu antiacide/lapte

38
Q

Acidul alginic

A

Efect protector al muc (gel vascos) si adsorbant

I: BRGE, gatrite, ulcer post-AINS

39
Q

Tripla terapie de eradicare a HP

A

Omeprazol (orice alt IPP) + Amoxicilina 2x1000mg + Claritromicina 2x500mg/Metronidazol 2x500 mg
timp de 14 zile

40
Q

Terapia cvadrupla de eradicare a HP

A

IPP + Bismut subcitrat coloidal 4x120 mg + Metronidazol 2x500 mg + Tetraciclina 4x500 mg
timp de 14 zile

41
Q

Terapia secventiala de eradicare a HP

A

IPP + Amoxicilina 2g/zi timp de 5-7 zile
apoi IPP + tinidazol 5-7 zile
apoi IPP + claritromicina 5-7 zile

42
Q

Terapia de intretinere pentru prevenirea activarii ulcerului

A

Antagonisti H2 (Ranitidina, Famotidina, Nizatidina) seara la culcare

43
Q

Tratamentul ulcerelor induse de folosirea medicamentelor (AINS)

A

IPP 40mg + Misoprostol 4x200microg/zi